Bob Holmen

Insider Reports History

Location
1405 Research Blvd., Ste. 125, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bob Holmen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 19,000 21 May 2025 Direct

Insider Reports Filed by Bob Holmen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 21 May 2025 1 $0 4 Director 23 May 2025, 16:30
SNSE Sensei Biotherapeutics, Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 17:08
SNSE Sensei Biotherapeutics, Inc. 10 Jul 2023 2 $0 4 Director 12 Jul 2023, 16:44
SNSE Sensei Biotherapeutics, Inc. 10 Jun 2022 2 $0 4 Director 14 Jun 2022, 16:15